4A10(Allterum Therapeutics)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug Name4A10(Allterum Therapeutics)
Drug Alias Name4A10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-7 receptor subunit alpha modulators
TargetsInterleukin-7 receptor subunit alpha
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllterum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllterum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A